Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
- 30 June 2011
- journal article
- Published by Elsevier BV in Journal of Infection
- Vol. 62 (6), 448-455
- https://doi.org/10.1016/j.jinf.2011.04.005
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Natural history of chronic hepatitis B REVEALedJournal of Gastroenterology and Hepatology, 2011
- Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991-2Gut, 2010
- Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment–Induced HepatotoxicityClinical Infectious Diseases, 2010
- Factors influencing time to smear conversion in patients with smear‐positive pulmonary tuberculosisRespirology, 2009
- Kinetics of hepatitis B virus load and haemodialysis: a prospective studyJournal of Viral Hepatitis, 2008
- Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicityInternational Journal of Antimicrobial Agents, 2008
- Rifampicin exacerbates isoniazid‐induced toxicity in human but not in rat hepatocytes in tissue‐like culturesBritish Journal of Pharmacology, 2008
- Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapyHepatology, 2006
- Antituberculosis drug-related liver dysfunction in chronic hepatitis B infectionHepatology, 2000
- Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.Thorax, 1996